Actos Bladder Cancer Trial Continues in Federal MDL
Trial continues for the first federal Actos bladder cancer lawsuit to go before a jury, but the court will recess this afternoon until March 10 due to Mardi Gras. The jury in Lafayette, Louisiana has...
View ArticleSide Effects of Actos at Low Doses Still Linked to Bladder Cancer: Study
Researchers from Korea indicate that side effects of Actos may increase the risk of bladder cancer even when low doses of the diabetes drug are used. According to a study published last month in the...
View ArticleActos Trial Underway in Las Vegas Over Bladder Cancer in Two Users
Trial began this week in Nevada state court involving product liability lawsuits filed by two women who claim they developed bladder cancer from Actos, alleging that Takeda Pharmaceuticals failed to...
View ArticleClosing Arguments to be Presented in Actos Bladder Cancer Trial
The first federal trial involving an Actos bladder cancer lawsuit is coming to a conclusion after 33 days of trial, with the jury scheduled to hear closing arguments on Monday before deliberations...
View ArticleActos Lawsuit Results in Landmark $9 Billion Punitive Damages Verdict
Following more than 12 weeks of trial, it took a Louisiana jury only a few hours to return a verdict in the first federal case involving the development of bladder cancer from side effects of Actos,...
View ArticleAfter Multi-Billion Dollar Actos Decision, Juries Return Defense Verdicts
Only weeks after a federal jury awarded issued a $9 billion damage award in an Actos lawsuit over bladder cancer, juries in Las Vegas and Chicago have both separately returned defense verdicts in favor...
View ArticleActos Documents Relevant to Lawsuits Intentionally Destroyed: Judge
The federal judge presiding over all Actos bladder cancer lawsuits has determined that Takeda Pharmaceuticals intentionally deleted or destroyed documents and other evidence that were relevant to the...
View ArticleTakeda Seeks New Trial Following $9B Actos Verdict
Following a landmark $9 billion verdict in an Actos bladder cancer lawsuit verdict earlier this year, Takeda Pharmaceuticals and Eli Lilly are seeking to have the judgment reversed or for a new trial,...
View ArticleJury Awards $2M in Damages for Bladder Cancer from Actos
Following trial in Pennsylvania state court, a Philadelphia jury decided late Friday to award more than $2 million to a woman diagnosed with bladder cancer following use of the popular diabetes drug...
View ArticlePunitive Damages in Actos Bladder Lawsuit Reduced to Maximum Allowed, Per Judge
The landmark $9 billion punitive damage award returned in the first federal Actos bladder cancer trial has been reduced to just $37 million by the judge presiding over the case, who suggested that the...
View ArticleClik here to view.
Top 10 Consumer Risks Uncovered in 2014
Over the past year, a number of surprising facts have emerged about serious and potentially life-threatening risks posed for consumers. From commonly used medical devices that are now known to spread...
View ArticleInformation on Actos Settlements, Filings, Other Progress in State Cases to...
As parties involved in the federal Actos bladder cancer lawsuits prepare to meet today for a status conference, the U.S. District Judge presiding over the litigation has issued a series of orders...
View ArticleActos Settlement Conferences Scheduled in Bladder Cancer MDL
With thousands of Actos lawsuits pending throughout the federal court system, all involving similar allegations that the makers of the diabetes drug failed to adequately warn about the risk of bladder...
View ArticleActos Bladder Cancer Settlement Will Result in $2.4B Payment to Resolve Lawsuits
Takeda Pharmaceuticals has agreed to pay nearly $2.4 billion to settle Actos lawsuits, which may resolve the litigation that alleges the drug maker failed to adequately warn consumers and the medical...
View ArticleActos Verdict of $6.5M in First Bladder Cancer Lawsuit Reinstated on Appeal
A California appeals court has decided to reinstate a $6.5 million damage award returned by the first jury to hear evidence about the link between Actos and bladder cancer, overturning a post-trial...
View ArticleActos Bladder Cancer Lawsuits Headed to Trial in Nevada After Some Reject...
Even after Takeda Pharmaceuticals offered to pay $2.37 billion to settle all Actos cases, the drug maker faces a high-profile trial that began last week in Nevada, involving two users of the popular...
View ArticleActos Settlement To Go Forward After Participation Threshold Reached
Takeda Pharmaceuticals indicates that a sufficient number of plaintiffs nationwide have agreed to settle their Actos bladder cancer lawsuits, so a previously announced $2.4 billion settlement program...
View ArticleActos Trial Resolved as Settlement Reached in Two Nevada Bladder Cancer Cases
After agreeing to pay $2.4 billion in Actos settlements to resolve thousands of claims brought by former users of the diabetes drug diagnosed with bladder cancer, Takeda Pharmaceuticals agreed to...
View ArticleJury Awards $2M in Damages for Bladder Cancer from Actos
Following trial in Pennsylvania state court, a Philadelphia jury decided late Friday to award more than $2 million to a woman diagnosed with bladder cancer following use of the popular diabetes drug...
View ArticlePunitive Damages in Actos Bladder Lawsuit Reduced to Maximum Allowed, Per Judge
The landmark $9 billion punitive damage award returned in the first federal Actos bladder cancer trial has been reduced to just $37 million by the judge presiding over the case, who suggested that the...
View Article
